Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.21.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Series D Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Total
Balances at beginning (in shares) at Mar. 31, 2019 500,000 1,160,240 2,318,012   42,758,630        
Balances at beginning at Mar. 31, 2019 $ 500 $ 1,200 $ 2,300   $ 42,800 $ 192,129,900 $ (3,968,100) $ (181,133,400) $ 7,075,200
Stock-based compensation expense           3,820,800     3,820,800
Accrued dividends on Series B Preferred stock           (1,263,600)     (1,263,600)
Proceeds from sale of common stock and warrants for cash in private placement offerings (in shares)         650,000        
Proceeds from sale of common stock and warrants for cash in private placement offerings         $ 600 649,400     $ 650,000
Issuance of common stock upon cashless exercise of stock options, shares                 0
Proceeds from sale of warrants in private placement           300,000     $ 300,000
Proceeds from sale of units of common stock and warrants for cash in public offering and concurrent private placement, shares         3,870,077        
Proceeds from sale of units of common stock and warrants for cash in public offering and concurrent private placement, amount         $ 3,900 2,695,100     2,699,000
Issuance of commitment shares and net proceeds of initial sale of common stock under equity line, shares         1,250,000        
Issuance of commitment shares and net proceeds of initial sale of common stock under equity line, amount         $ 1,200 525,100     526,300
Proceeds from exercise of warrants (in shares)         820,000        
Proceeds from exercise of warrants         $ 800 409,200     410,000
Increase in fair value attributable to warrant modifications           826,900     826,900
Net loss   (20,774,000)
Balances at end (in shares) at Mar. 31, 2020 500,000 1,160,240 2,318,012   49,348,707        
Balances at end at Mar. 31, 2020 $ 500 $ 1,200 $ 2,300 $ 0 $ 49,300 200,092,800 (3,968,100) (201,907,400) (5,729,400)
Stock-based compensation expense           2,306,100     2,306,100
Accrued dividends on Series B Preferred stock           (1,385,600)     (1,385,600)
Proceeds from sale of common stock under equity line, shares         6,301,995        
Proceeds from sale of common stock under equity line, amount         $ 6,300 2,790,500     2,796,800
Net proceeds from sale of common stock in public offering, shares         17,868,250        
Net proceeds from sale of common stock in public offering, amount         $ 17,900 12,887,200     12,905,100
Net proceeds from sale of common stock and Series D Preferred Stock in public offering, shares       2,000,000 63,000,000        
Net proceeds from sale of common stock and Series D Preferred Stock in public offering, amount       $ 2,000 $ 63,000 93,582,900     93,647,900
Conversion of Series D Preferred stock to common stock, shares       (1,597,851) 36,750,573        
Conversion of Series D Preferred stock to common stock, amount       $ (1,600) $ 36,800 (35,200)     0
Conversion of Series B Preferred stock to common stock and payment of accrued dividends in common stock, shares   (28,571)     188,633        
Conversion of Series B Preferred stock to common stock and payment of accrued dividends in common stock, amount   $ (100)     $ 200 124,500     124,600
Sale of common stock pursuant to 2019 Employee Stock Purchase Plan, shares         58,125        
Sale of common stock pursuant to 2019 Employee Stock Purchase Plan, amount         $ 100 26,100     $ 26,200
Issuance of common stock upon cashless exercise of stock options, shares         222,004       355,000
Issuance of common stock upon cashless exercise of stock options, amount         $ 200 (200)     $ 0
Net proceeds from exercise of stock options for cash, shares         30,000        
Net proceeds from exercise of stock options for cash, amount         $ 0 36,500     36,500
Issuance of common stock at fair value for professional services, shares         233,645        
Issuance of common stock at fair value for professional services, amount         $ 200 124,800     125,000
Beneficial conversion feature on Series D Preferred stock           23,000,000     23,000,000
Proceeds from exercise of warrants (in shares)         6,624,302        
Proceeds from exercise of warrants         $ 6,600 5,002,900     5,009,500
Deemed dividend from beneficial conversion feature of Series D Preferred Stock           (23,000,000)     23,000,000
Net loss               (17,934,200) (17,934,200)
Balances at end (in shares) at Mar. 31, 2021 500,000 1,131,669 2,318,012 402,149 180,751,234        
Balances at end at Mar. 31, 2021 $ 500 $ 1,100 $ 2,300 $ 400 $ 180,800 $ 315,603,100 $ (3,968,100) $ (219,841,600) $ 91,978,500